CLINICAL EVALUATION OF CEFROXADINE (CGP-9000) IN URINARY TRACT INFECTIONS

DOI Web Site

Bibliographic Information

Other Title
  • 尿路感染症に対するCefroxadine (CGP-9000) の臨床的検討
  • ニョウロ カンセンショウ ニ タイスル Cefroxadine CGP 900

Search this article

Abstract

Cefroxadine (CGP-9000, CXD) a new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum was administered orally 250mg 2-3 times a day to 31 patients with urinary tract infections to evaluate therapeutic efficacy. The results obtained as follows:<BR>1) The clinical effects for 24 patients with acute simple cystitis were excellent in 11 cases (45.8%), moderate in 12 cases (50%) and poor in 1 case (4.2%).<BR>2) The clinical effects for 7 patients with chronic complicated urinary tract infections were excellent in 1 case (14.3%), moderate in 3 cases (42.9%) and poor in 3 cases (42.9%).<BR>3) No marked side effects were observed.

Journal

  • CHEMOTHERAPY

    CHEMOTHERAPY 28 (Supplement3), 387-395, 1980

    Japanese Society of Chemotherapy

Details 詳細情報について

Report a problem

Back to top